Han Hyun Jung, Ko Myung Jin, Park Ahyoung, Cheun Jaemin, Nam Yeonjoo, Kim Tae Hui
Silvia Health Inc., Seoul, South Korea.
Department of Psychiatry, Yonsei University Wonju Christian Hospital, Wonju, Korea.
Digit Health. 2024 Oct 10;10:20552076241284810. doi: 10.1177/20552076241284810. eCollection 2024 Jan-Dec.
The heterogeneous etiology of mild cognitive impairment (MCI) presents significant challenges in monitoring its progression and impeding its advancement toward dementia. Digital multidomain lifestyle interventions have shown promise as potential solutions for their ability to treat MCI.
This study is the first phase in a series of evaluations aimed at assessing various components of Silvia-Rx, which was originally designed as a digital multidomain lifestyle intervention. Specifically, this study focused on a 60-session core cognitive training program to evaluate its feasibility and efficacy in addressing cognitive decline in individuals with MCI.
Individuals aged 60 to 80 years diagnosed with MCI were enrolled to participate in a 60-session tablet-based cognitive regimen of Silvia-Rx. Feasibility was assessed through adherence and retention rates, while the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-cog) scale was utilized to measure cognitive function as the primary indicator of efficacy.
The mean age of the participants was 71.11 years, and 13 (68.42%) were women. Only one withdrawal occurred, resulting in a 95% retention rate (19 participants) post-intervention. The completion rate was excellent at 100%, indicating that the 60-session core cognitive program in Silvia-Rx was well tolerated by older participants with MCI. Regarding efficacy, there was a statistically significant improvement in cognitive function among MCI participants after the intervention, as evidenced by changes in total ADAS-cog scores.
Results demonstrated excellent adherence throughout the program and significant cognitive improvements after the intervention. This pilot study indicates that Silvia-Rx's digital cognitive program is feasible for people diagnosed with MCI, suggests potential for improving cognitive function, though further research with large sample size is needed to confirm these results.
轻度认知障碍(MCI)病因各异,这在监测其进展以及阻止其向痴呆症发展方面带来了重大挑战。数字多领域生活方式干预因其治疗MCI的能力而显示出有望成为潜在解决方案。
本研究是一系列评估的第一阶段,旨在评估Silvia-Rx的各个组成部分,该方案最初设计为数字多领域生活方式干预。具体而言,本研究聚焦于一个为期60节的核心认知训练项目,以评估其在解决MCI个体认知衰退方面的可行性和有效性。
招募年龄在60至80岁、被诊断为MCI的个体,参与基于平板电脑的Silvia-Rx为期60节的认知方案。通过依从率和保留率评估可行性,同时使用阿尔茨海默病评估量表-认知(ADAS-cog)量表来测量认知功能,作为疗效的主要指标。
参与者的平均年龄为71.11岁,13名(68.42%)为女性。仅发生了1例退出,干预后保留率为95%(19名参与者)。完成率极佳,为100%,这表明Silvia-Rx中为期60节的核心认知项目在患有MCI的老年参与者中耐受性良好。关于疗效,干预后MCI参与者的认知功能有统计学上的显著改善,总ADAS-cog评分的变化证明了这一点。
结果表明在整个项目中依从性极佳,干预后认知有显著改善。这项初步研究表明,Silvia-Rx的数字认知项目对被诊断为MCI的人是可行的,显示出改善认知功能的潜力,不过需要进一步的大样本研究来证实这些结果。